ANDERSON; Christen M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for ANDERSON; Christen M..The latest application filed is for "methods of treatment".

Company Profile

1.13.23

ANDERSON; Christen M. - Tulsa OK
Anderson; Christen M. - Encinitas CA
Anderson; Christen M. - San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods Of Treatment App 20200368190 - ADAMS; John W. ; et al.	2020-11-26
Administration of an anti-obesity compound to individuals with renal impairment Grant 9,770,455 - Anderson , et al. September 26, 2	2017-09-26
Administration Of An Anti-obesity Compound To Individuals With Renal Impairment App 20170216307 - Anderson; Christen M. ; et al.	2017-08-03
Administration Of An Anti-obesity Compound To Individuals With Renal Impairment App 20150196567 - Anderson; Christen M. ; et al.	2015-07-16
Administration of an anti-obesity compound to individuals with renal impairment Grant 8,999,970 - Anderson , et al. April 7, 2	2015-04-07
5-ht2c Receptor Agonists In The Treatment Of Disorders Ameliorated By Reduction Of Norepinephrine Level App 20130267500 - Anderson; Christen M. ; et al.	2013-10-10
Methods of treating obesity with two different anti-obesity agents Grant 8,394,765 - Roth , et al. March 12, 2	2013-03-12
Administration Of An Anti-obesity Compound To Individuals With Renal Impairment App 20120252787 - Anderson; Christen M. ; et al.	2012-10-04
Methods for treating obesity and obesity related diseases and disorders App 20090156474 - Roth; Jonathan D. ; et al.	2009-06-18
Methods for Treating Obesity and Obesity Related and Disorders App 20080207512 - Roth; Jonathan D. ; et al.	2008-08-28
Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor Grant 7,001,729 - Anderson , et al. February 21, 2	2006-02-21
Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor. Grant 6,906,175 - Anderson , et al. June 14, 2	2005-06-14
Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor Grant 6,906,174 - Anderson , et al. June 14, 2	2005-06-14
Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor Grant 6,906,173 - Anderson , et al. June 14, 2	2005-06-14
Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor Grant 6,902,908 - Anderson , et al. June 7, 2	2005-06-07
Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor Grant 6,887,670 - Anderson , et al. May 3, 2	2005-05-03
Production Of Adenine Nucleotide Translocator (ant), Novel Ant Ligands And Screening Assays Therefor App 20050064530 - Anderson, Christen M. ; et al.	2005-03-24
Production Of Adenine Nucleotide Translocator (ant), Novel Ant Ligands And Screening Assays Therefor App 20050019835 - Anderson, Christen M. ; et al.	2005-01-27
Production Of Adenine Nucleotide Translocator (ant), Novel Ant Ligands And Screening Assays Therefor App 20050003352 - Anderson, Christen M. ; et al.	2005-01-06
Production Of Adenine Nucleotide Translocator (ant), Novel Ant Ligands And Screening Assays Therefor App 20050003353 - Anderson, Christen M. ; et al.	2005-01-06
Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor App 20040241801 - Anderson, Christen M. ; et al.	2004-12-02
Compositions and methods for regulating endogenous inhibitor of ATP synthase, including treatment for diabetes App 20040072739 - Anderson, Christen M. ; et al.	2004-04-15
Indicators of altered mitochondrial function in predictive methods for determining risk of type 2 diabetes mellitus App 20030235812 - Anderson, Christen M. ; et al.	2003-12-25
Indicators of altered mitochondrial function in predictive methods for determining risk of type 2 diabetes mellitus Grant 6,653,094 - Anderson , et al. November 25, 2	2003-11-25
Production Of Adenine Nucleotide Translocator (ant), Novel Ant Lgands And Screening Assays Therrfor App 20020177185 - ANDERSON, CHRISTEN M. ; et al.	2002-11-28
Cellular And Animal Models For Diseases Associated With Altered Mitochondrial Function App 20020106354 - ANDERSON, CHRISTEN M. ; et al.	2002-08-08
Inhibition of mitochondrial calcium/sodium antiporter App 20020082193 - Anderson, Christen M. ; et al.	2002-06-27
Modulation of mitochondrial mass and function for the treatment of diseases and for target and drug discovery App 20020049176 - Anderson, Christen M. ; et al.	2002-04-25
Indicators of altered mitochondrial function in predictive methods for determining risk of type 2 diabetes mellitus App 20020031759 - Anderson, Christen M. ; et al.	2002-03-14
Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor App 20020012992 - Anderson, Christen M. ; et al.	2002-01-31
Cellular and animal models for diseases associated with altered mitochondrial function App 20020004043 - Anderson, Christen M. ; et al.	2002-01-10
Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor App 20010044144 - Anderson, Christen M. ; et al.	2001-11-22
Indicators of altered mitochondrial function in predictive methods for determining risk of type 2 diabetes mellitus Grant 6,140,067 - Anderson , et al. October 31, 2	2000-10-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.